juli, a Boston, MA-based AI-powered digital health platform empowering patients and their care teams to manage complex chronic conditions, raised $3.8m in seed funding.
The round was led by Speedinvest, and Norrsken VC, with participation from SoftBank’s Vision Fund Emerge Program and Dieter von Holtzbrinck Ventures.
The company intends to use the funds to scale its commercial team across the U.S., conduct clinical trials of the app, and acquire additional artificial intelligence talent.
Led by Bettina Hein, CEO and co-founder, and Bettina Duehrkoop, Chief Marketing Officer, juli leverages AI to help patients (and their caregivers) gain control over their conditions by giving them insight into the behavioral patterns that impact their health, like pinpointing triggers that make a complex, multifactorial condition worse, and identifying changes that can help avoid or alleviate a flare-up.
Since launching a year ago, approximately 15,000 patients have used the app to track data for chronic, debilitating conditions.
FinSMEs
03/03/2022